These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37507250)

  • 1. [Diagnosis and treatment of iron overload].
    Ruivard M; Lobbes H
    Rev Med Interne; 2023 Dec; 44(12):656-661. PubMed ID: 37507250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperferritinemia - investigation, diagnosis and treatment].
    Melas N; Stål P
    Lakartidningen; 2024 Oct; 121():. PubMed ID: 39411810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
    Ruivard M
    Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron deficiency and overload.
    Beutler E; Hoffbrand AV; Cook JD
    Hematology Am Soc Hematol Educ Program; 2003; ():40-61. PubMed ID: 14633776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
    Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
    Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Liver Iron Concentration Can Guide Venesection Decision-Making in Hyperferritinemia.
    Bhuva M; Patterson I; Godfrey EM; Bowden DJ; Griffiths WJH
    Dig Dis Sci; 2023 Jun; 68(6):2704-2709. PubMed ID: 36929239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary and acquired iron overload].
    de Korwin JD
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload disorders.
    Hsu CC; Senussi NH; Fertrin KY; Kowdley KV
    Hepatol Commun; 2022 Aug; 6(8):1842-1854. PubMed ID: 35699322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
    Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Laboratory Associations with Persistent Hyperferritinemia in 373 Black Hemochromatosis and Iron Overload Screening Study Participants.
    Barton JC; Barton JC; Adams PC
    Ann Hepatol; 2017; 16(5):802-811. PubMed ID: 28809726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.
    Viveiros A; Schaefer B; Panzer M; Henninger B; Plaikner M; Kremser C; Franke A; Franzenburg S; Hoeppner MP; Stauder R; Janecke A; Tilg H; Zoller H
    Hepatology; 2021 Nov; 74(5):2424-2435. PubMed ID: 34048062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD004450. PubMed ID: 23963793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.
    Phatak P; Brissot P; Wurster M; Adams PC; Bonkovsky HL; Gross J; Malfertheiner P; McLaren GD; Niederau C; Piperno A; Powell LW; Russo MW; Stoelzel U; Stremmel W; Griffel L; Lynch N; Zhang Y; Pietrangelo A
    Hepatology; 2010 Nov; 52(5):1671-779. PubMed ID: 20814896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification and diagnosis of iron overload.
    Piperno A
    Haematologica; 1998 May; 83(5):447-55. PubMed ID: 9658731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hereditary hemochromatosis].
    Dantas W
    Rev Gastroenterol Peru; 2001; 21(1):42-55. PubMed ID: 12170286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EASL Clinical Practice Guidelines on haemochromatosis.
    European Association for the Study of the Liver
    J Hepatol; 2022 Aug; 77(2):479-502. PubMed ID: 35662478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.